CD47 and cancer: used gene‐edited strategy to make cell overexpress SIRPα variants (Figure 10).[220] The SIRPα variants possess remarkable affinity to effectively block CD47‐SIRPα axis, thereby enhancing the phagocytosis of cancer cells by macrophages.